Monoclonal antibody–standardized cat extract immunotherapy: Risk-benefit effects from a double-blind placebo study
- 31 March 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 93 (3) , 556-566
- https://doi.org/10.1016/s0091-6749(94)70067-2
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- The control of allergens of dust mites and domestic pets: a position paperClinical and Experimental Allergy, 1992
- Studies on the biochemical structure of the major cat allergen Felis domesticus IMolecular Immunology, 1991
- Responses to ragweed-pollen nasal challenge before and after immunotherapyJournal of Allergy and Clinical Immunology, 1989
- Immunotherapy with dog and cat extracts in childrenAllergy, 1989
- Characterization of the Main IgE-Binding Components of Cat DanderInternational Archives of Allergy and Immunology, 1987
- Diagnosis and Immunotherapy of Mould AllergyAllergy, 1986
- Standardization of AllergensAllergy, 1983
- Standardization of Allergens: Lectins and Monoclonal Antibodies as Primary Standards for House Dust Mite AllergensInternational Archives of Allergy and Immunology, 1981
- Pet sensitivities in asthmatic children.Archives of Disease in Childhood, 1976
- Value of Inhalation Tests in Bronchial AsthmaRespiration, 1969